Clinical Trial Update: Molecular Screening Method for Preeclampsia (PREMOM)

View source ↗

Summary

A clinical trial evaluating a molecular screening method for preeclampsia (NCT04990141) sponsored by iPremom has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Snippet

Sponsor: iPremom | Conditions: Preeclampsia | Status: COMPLETED